Intravenous (IV) orders will be automatically converted to enteral (PO) product for eligible patients. See Protocol 916.6007
For use in Surgical Antimicrobial Prophylaxis, see Guideline 916.5004
P&T approved the use of metronidazole BID dosing (rather than TID), with the following exceptions: pediatrics and when used to treat Clostridiodes difficile infections, CNS infections, infections caused by ameba, and Helicobacter pylori
Intravenous (IV) orders will be automatically converted to enteral (PO) product for eligible patients. See Protocol 916.6007
For use in Surgical Antimicrobial Prophylaxis, see Guideline 916.5004
P&T approved the use of metronidazole BID dosing (rather than TID), with the following exceptions: pediatrics and when used to treat Clostridiodes difficile infections, CNS infections, infections caused by ameba, and Helicobacter pylori